231 related articles for article (PubMed ID: 38789421)
1. Deleting the mitochondrial respiration negative regulator MCJ enhances the efficacy of CD8
Wu MH; Valenca-Pereira F; Cendali F; Giddings EL; Pham-Danis C; Yarnell MC; Novak AJ; Brunetti TM; Thompson SB; Henao-Mejia J; Flavell RA; D'Alessandro A; Kohler ME; Rincon M
Nat Commun; 2024 May; 15(1):4444. PubMed ID: 38789421
[TBL] [Abstract][Full Text] [Related]
2. Fine-Tuning of CD8(+) T Cell Mitochondrial Metabolism by the Respiratory Chain Repressor MCJ Dictates Protection to Influenza Virus.
Champagne DP; Hatle KM; Fortner KA; D'Alessandro A; Thornton TM; Yang R; Torralba D; Tomás-Cortázar J; Jun YW; Ahn KH; Hansen KC; Haynes L; Anguita J; Rincon M
Immunity; 2016 Jun; 44(6):1299-311. PubMed ID: 27234056
[TBL] [Abstract][Full Text] [Related]
3. MCJ/DnaJC15, an endogenous mitochondrial repressor of the respiratory chain that controls metabolic alterations.
Hatle KM; Gummadidala P; Navasa N; Bernardo E; Dodge J; Silverstrim B; Fortner K; Burg E; Suratt BT; Hammer J; Radermacher M; Taatjes DJ; Thornton T; Anguita J; Rincon M
Mol Cell Biol; 2013 Jun; 33(11):2302-14. PubMed ID: 23530063
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial arginase-2 is a cell‑autonomous regulator of CD8+ T cell function and antitumor efficacy.
Martí i Líndez AA; Dunand-Sauthier I; Conti M; Gobet F; Núñez N; Hannich JT; Riezman H; Geiger R; Piersigilli A; Hahn K; Lemeille S; Becher B; De Smedt T; Hugues S; Reith W
JCI Insight; 2019 Nov; 4(24):. PubMed ID: 31751318
[TBL] [Abstract][Full Text] [Related]
5. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
[TBL] [Abstract][Full Text] [Related]
6. The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent.
Goikoetxea-Usandizaga N; Bravo M; Egia-Mendikute L; Abecia L; Serrano-Maciá M; Urdinguio RG; Clos-García M; Rodríguez-Agudo R; Araujo-Legido R; López-Bermudo L; Delgado TC; Lachiondo-Ortega S; González-Recio I; Gil-Pitarch C; Peña-Cearra A; Simón J; Benedé-Ubieto R; Ariño S; Herranz JM; Azkargorta M; Salazar-Bermeo J; Martí N; Varela-Rey M; Falcón-Pérez JM; Lorenzo Ó; Nogueiras R; Elortza F; Nevzorova YA; Cubero FJ; Saura D; Martínez-Cruz LA; Sabio G; Palazón A; Sancho-Bru P; Elguezabal N; Fraga MF; Ávila MA; Bataller R; Marín JJG; Martín F; Martínez-Chantar ML
Hepatology; 2023 Sep; 78(3):878-895. PubMed ID: 36745935
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals.
Goikoetxea-Usandizaga N; Serrano-Maciá M; Delgado TC; Simón J; Fernández Ramos D; Barriales D; Cornide ME; Jiménez M; Pérez-Redondo M; Lachiondo-Ortega S; Rodríguez-Agudo R; Bizkarguenaga M; Zalamea JD; Pasco ST; Caballero-Díaz D; Alfano B; Bravo M; González-Recio I; Mercado-Gómez M; Gil-Pitarch C; Mabe J; Gracia-Sancho J; Abecia L; Lorenzo Ó; Martín-Sanz P; Abrescia NGA; Sabio G; Rincón M; Anguita J; Miñambres E; Martín C; Berenguer M; Fabregat I; Casado M; Peralta C; Varela-Rey M; Martínez-Chantar ML
Hepatology; 2022 Mar; 75(3):550-566. PubMed ID: 34510498
[TBL] [Abstract][Full Text] [Related]
8. Adoptive transfer of siRNA Cblb-silenced CD8+ T lymphocytes augments tumor vaccine efficacy in a B16 melanoma model.
Hinterleitner R; Gruber T; Pfeifhofer-Obermair C; Lutz-Nicoladoni C; Tzankov A; Schuster M; Penninger JM; Loibner H; Lametschwandtner G; Wolf D; Baier G
PLoS One; 2012; 7(9):e44295. PubMed ID: 22962608
[TBL] [Abstract][Full Text] [Related]
9. Significant anti-tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8(+) T cell/regulatory T cells in tumour.
Song S; Zhang K; You H; Wang J; Wang Z; Yan C; Liu F
Clin Exp Immunol; 2010 Oct; 162(1):75-83. PubMed ID: 20735440
[TBL] [Abstract][Full Text] [Related]
10. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
Dobrzanski MJ; Reome JB; Hollenbaugh JA; Dutton RW
J Immunol; 2004 Feb; 172(3):1380-90. PubMed ID: 14734713
[TBL] [Abstract][Full Text] [Related]
11. Targeting Protein Tyrosine Phosphatase 22 Does Not Enhance the Efficacy of Chimeric Antigen Receptor T Cells in Solid Tumors.
Du X; Darcy PK; Wiede F; Tiganis T
Mol Cell Biol; 2022 Mar; 42(3):e0044921. PubMed ID: 35041491
[TBL] [Abstract][Full Text] [Related]
12. Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.
Lutz-Nicoladoni C; Wallner S; Stoitzner P; Pircher M; Gruber T; Wolf AM; Gastl G; Penninger JM; Baier G; Wolf D
Immunol Cell Biol; 2012 Jan; 90(1):130-4. PubMed ID: 21383769
[TBL] [Abstract][Full Text] [Related]
13. IL7-Fc Enhances the Efficacy of Adoptive T Cell Therapy under Lymphopenic Conditions in a Murine Melanoma Model.
Yu EM; Cho E; Singh R; Kim SH; Han C; Han S; Lee DG; Kim YH; Kwon BS; Choi BK
Cells; 2021 Aug; 10(8):. PubMed ID: 34440787
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of SHP-1 Expands the Repertoire of Antitumor T Cells Available to Respond to Immune Checkpoint Blockade.
Snook JP; Soedel AJ; Ekiz HA; O'Connell RM; Williams MA
Cancer Immunol Res; 2020 Apr; 8(4):506-517. PubMed ID: 32075800
[TBL] [Abstract][Full Text] [Related]
15. Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.
Saenger YM; Li Y; Chiou KC; Chan B; Rizzuto G; Terzulli SL; Merghoub T; Houghton AN; Wolchok JD
Cancer Res; 2008 Dec; 68(23):9884-91. PubMed ID: 19047169
[TBL] [Abstract][Full Text] [Related]
16. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
Dobrzanski MJ; Reome JB; Dutton RW
J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
[TBL] [Abstract][Full Text] [Related]
17. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of lymphotactin and interferon gamma-inducible protein-10 transgene expression in T-cell localization and adoptive T-cell therapy of tumors.
Huang H; Xiang J
Int J Cancer; 2004 May; 109(6):817-25. PubMed ID: 15027114
[TBL] [Abstract][Full Text] [Related]
19. Adoptive immunotherapy with transient anti-CD4 treatment enhances anti-tumor response by increasing IL-18Rα
Kim SH; Cho E; Kim YI; Han C; Choi BK; Kwon BS
Nat Commun; 2021 Sep; 12(1):5314. PubMed ID: 34493727
[TBL] [Abstract][Full Text] [Related]
20. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
